Jim Kling. Show Affiliations »
Abstract
Mesh: See more » Biosimilar PharmaceuticalsBiotechnologyClinical Trials as TopicDrug IndustryHumansPharmaceutical PreparationsPrecision MedicineUnited StatesUnited States Food and Drug Administration
Substances: See more » Biosimilar PharmaceuticalsPharmaceutical Preparations
Year: 2014 PMID: 24509747 DOI: 10.1038/nbt.2811
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908